Courtney Hanak, MD, and Ravi Ambani, MD, discuss limb preservation and amputation prevention in patients with peripheral arterial disease and chronic limb-threatening ischemia. They review diagnostic approaches to assess perfusion and tissue viability, current revascularization strategies for limb salvage, wound care, factors that influence amputation decisions and emerging technologies shaping the future of limb preservation.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Ashish Sarraju, MD, and Leslie Cho, MD, discuss key updates in the 2026 ACC/AHA cholesterol guidelines, including earlier LDL screening and integration of the PREVENT risk calculator. They explore clinical implications of Lp(a) testing, risk stratification and expanding therapeutic options to help patients achieve evidence-based lipid goals.

Read more about the guidelines: https://consultqd.clevelandclinic.org/counseling-patients-on-the-new-cholesterol-guideline

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Michael Zhen-Yu Tong, MD, and Sanjeeb Bhattacharya, MD, discuss the clinical management of heart transplant patients during the first year, including immunosuppression strategies, rejection surveillance and complication recognition. They also highlight evolving technologies, donor expansion and collaborative care approaches that are improving outcomes in advanced heart failure and transplantation.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Oussama Wazni, MD, MBA, and Mohamed Kanj, MD, discuss the clinical rationale and outcomes behind combining atrial fibrillation ablation with left atrial appendage closure, including insights from the OPTION trial. They examine patient selection, procedural considerations and the impact of pulsed field ablation on safety, efficiency and long-term stroke prevention strategies.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Grant Reed, MD, and Laura Young, MD, discuss contemporary decision making in percutaneous coronary intervention, including patient selection, ischemia assessment and the role of medical therapy. They explore advances in imaging, plaque modification and hybrid revascularization strategies for complex coronary artery disease.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Gayan De Silva, MD, and Kathleen Boyle, DO, discuss clinical evaluation and treatment of patients with spider veins, including differentiation from underlying venous and arterial disease and appropriate patient selection. Learn about technique considerations for foam and liquid sclerotherapy, expected outcomes, and long-term management.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Samir Kapadia, MD, and Ohad Oren, MD, examine clonal hematopoiesis of indeterminate potential (CHIP) and its role as a causal driver of cardiovascular disease. They discuss mutation-specific risk, implications for prevention and how CHIP informs cardiovascular genomics and precision medicine.

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.

Walid Saliba, MD, and Oussama Wazni, MD, discuss the design and outcomes of the AVANT GUARD study evaluating first-line pulsed field ablation in drug-naive patients with persistent atrial fibrillation. The conversation explores efficacy endpoints, safety findings, and the implications for early rhythm control and disease progression.
Read more about the study. https://consultqd.clevelandclinic.org/pulsed-field-ablation-for-initial-treatment-of-persistent-af

Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.